↓ Skip to main content

On the interactions between mesenchymal stem cells and regulatory T cells for immunomodulation in transplantation

Overview of attention for article published in Frontiers in immunology, January 2012
Altmetric Badge

About this Attention Score

  • Average Attention Score compared to outputs of the same age and source

Mentioned by

linkedin
1 LinkedIn user

Citations

dimensions_citation
70 Dimensions

Readers on

mendeley
78 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
On the interactions between mesenchymal stem cells and regulatory T cells for immunomodulation in transplantation
Published in
Frontiers in immunology, January 2012
DOI 10.3389/fimmu.2012.00126
Pubmed ID
Authors

Anja U. Engela, Carla C. Baan, Frank J. M. F. Dor, Willem Weimar, Martin J. Hoogduijn

Abstract

Experimental studies have established the use of mesenchymal stem cells (MSC) as a candidate immunosuppressive therapy. MSC exert their immunomodulatory function through the inhibition of CD4(+) and CD8(+) T cell proliferation. It is unknown whether MSC impair the immunosuppressive function of regulatory T cells (Treg). In vitro and in vivo studies suggest that MSC mediate their immunomodulatory effects through the induction of Treg. In this review we will focus on the interactions between MSC and Treg, and evaluate the consequences of these cellular interplays for prospective MSC immunotherapy in organ transplantation.

Timeline

Login to access the full chart related to this output.

If you don’t have an account, click here to discover Explorer

Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 78 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Japan 1 1%
Germany 1 1%
Unknown 76 97%

Demographic breakdown

Readers by professional status Count As %
Researcher 16 21%
Student > Ph. D. Student 13 17%
Student > Bachelor 10 13%
Student > Master 10 13%
Student > Postgraduate 6 8%
Other 11 14%
Unknown 12 15%
Readers by discipline Count As %
Agricultural and Biological Sciences 24 31%
Medicine and Dentistry 14 18%
Biochemistry, Genetics and Molecular Biology 12 15%
Immunology and Microbiology 8 10%
Neuroscience 2 3%
Other 5 6%
Unknown 13 17%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 1. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 18 May 2012.
All research outputs
#21,519,690
of 26,414,132 outputs
Outputs from Frontiers in immunology
#25,834
of 33,172 outputs
Outputs of similar age
#209,027
of 254,644 outputs
Outputs of similar age from Frontiers in immunology
#147
of 274 outputs
Altmetric has tracked 26,414,132 research outputs across all sources so far. This one is in the 10th percentile – i.e., 10% of other outputs scored the same or lower than it.
So far Altmetric has tracked 33,172 research outputs from this source. They typically receive more attention than average, with a mean Attention Score of 8.6. This one is in the 13th percentile – i.e., 13% of its peers scored the same or lower than it.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 254,644 tracked outputs that were published within six weeks on either side of this one in any source. This one is in the 8th percentile – i.e., 8% of its contemporaries scored the same or lower than it.
We're also able to compare this research output to 274 others from the same source and published within six weeks on either side of this one. This one is in the 40th percentile – i.e., 40% of its contemporaries scored the same or lower than it.